Skip to main content
. 2024 Nov 26;2024(11):CD013707. doi: 10.1002/14651858.CD013707.pub2

3.3. Analysis.

3.3

Comparison 3: Pairwise analysis: milrinone versus placebo, Outcome 3: Thrombocytopaenia